Bioequivalence and Bioavailability Forum

Dear Rahul,

The most responsive email contact I have at this group is Rachana who can be reached on
shivrathclinicalgmail.com.

Incidentally some of you may be interested to know there was quite an interesting webinar last week that is currently available for replay on the Pharsight website:
Pharsight's Critical Path Approach for Development of Generic Products
Date: November 12, 2008
Time: 10:00am - 11:00am EST
Speakers: Jean-Francois Marier, PhD, FCP, Vice President & Lead Scientist, Reporting and Analysis Services; Jean-Sébastien Brunet, MSc, Senior Associate, Statistics and Data Management, Reporting and Analysis Services.

This webinar presents state-of-the-art pharmacokinetic and statistical analyses that can be used to assess bioequivalence of locally acting and highly variable drugs. The webinar will also present multiple examples showing how Pharsight's approach can save time and money in the development of a generic product with the use of IVIVC, biowaivers, bioassay validation, short-paneled or under-recruited studies, interim analysis, sequential bioequivalence studies, and sample pooling for preliminary assessment of bioequivalence.

---

Edit (@Simon): E-mail address removed to prevent spamming. Commercial content removed according to the Forum's Policy. For training & events see Pharsight's website. [Helmut]